[Intermittent treatment of "intractable chronic tuberculosis" by combined rifampicin-ethambutol: preliminary results of a controlled survey made in Algeria].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000462:Algeria; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D004357:Drug Synergism; D004977:Ethambutol / Q000627:therapeutic use*; D006801:Humans; D008875:Middle Aged; D012293:Rifampin / Q000627:therapeutic use*; D013997:Time Factors; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*
D004977:Ethambutol; D012293:Rifampin
Le traitement intermittent de la "tuberculose chronique invétérée" par l'association rifampicine-éthambutol: résultats préliminaires d'une enquête contrôlée menée à Alger.